oxidopamine has been researched along with Ventricular Dysfunction, Left in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mircoli, L | 1 |
| Fedele, L | 1 |
| Benetti, M | 1 |
| Bolla, GB | 1 |
| Radaelli, A | 1 |
| Perlini, S | 1 |
| Ferrari, AU | 1 |
1 other study available for oxidopamine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catechol | 2002 |